News
Feb 04, 2026

Paean Bio Targets Autoimmune and Tumor with 'MT Transplant Platform'

Paean Bio Targets Autoimmune and Tumor with 'MT Transplant Platform'

Paean Bio Targets Autoimmune and Tumor with 'MT Transplant Platform'

Source: http://m.biospectator.com/view/news_view.php?varAtcId=8243
1,108 views
Share:

Related News

More Updates From Our Research Journey

News Paean Bio "Developing mitochondrial treatments for rare diseases and cancer... Full-scale clinical trials next year"

Paean Bio "Developing mitochondrial treatments for rare diseases and cancer... Full-scale clinical trials next year"

Feb 04, 2026

Paean Bio "Developing mitochondrial treatments for rare diseases and cancer... F...

Read More
News [Live Report] Bio companies including BiocurePharm and Paean gather... Fierce technology competition

[Live Report] Bio companies including BiocurePharm and Paean gather... Fierce technology competition

Feb 04, 2026

[Live Report] Bio companies including BiocurePharm and Paean gather... Fierce te...

Read More
News World's first clinical trial for mitochondrial therapeutic... From immune cell therapy to anticancer drugs

World's first clinical trial for mitochondrial therapeutic... From immune cell therapy to anticancer drugs

Feb 01, 2026

World's first clinical trial for mitochondrial therapeutic... From immune cell t...

Read More
News Paean Bio "Discussing CMO contract for European clinical trials"

Paean Bio "Discussing CMO contract for European clinical trials"

Feb 01, 2026

Source: https://www.hankyung.com/article/202112071993i

Read More
Logo

Headquarter : 108SB, DaeduckBiz Center
17 Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea

Mail : info@paeanbio.com

Phone : 042-334-7378 | Fax : 042-334-7096

Navigation

Other

Copyrights © 2026 All Rights Reserved by PAEAN BIOTECHNOLOGY